Evaluation of Tetrix Cream as a Protective Barrier Against Injurious Materials

A Study to Determine the Skin Barrier Effect of Tetrix Cream

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00643630

Enrollment

Registered

2008-03-26

Start date

2007-10-31

Completion date

2007-11-30

Last updated

2008-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

Tetrix crea, skin barrier, antigen reaction, prevention, The efficacy of Tetrix Cream to prevent an antigen reaction on the skin.

Brief summary

To determine if Tetrix Cream,, when applied to the skin, acts as a barrier to prevent injury to the skin

Interventions

DEVICETetrix

Twice daily topical application

Study design

Allocation

RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

PREVENTION

Masking

SINGLE (Investigator)

Eligibility

Sex/Gender

ALL

Age

18 Years to 50 Years

Healthy volunteers

Yes

Inclusion criteria

* Normal subjects who are sensitized to nickel, neomycin, or fragrance mix.

Exclusion criteria

* Under 18 years of age.

Design outcomes

Primary

Measure	Time frame
Prevention of delayed bype hypersensitivity reaction following application of antigen	up to 96 hours after antigen application

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026